Chemoinformaics analysis of 2H-Thiopyran-3(6H)-one
| Molecular Weight | 114.169 | nRot | 0 |
| Heavy Atom Molecular Weight | 108.121 | nRig | 1 |
| Exact Molecular Weight | 114.014 | nRing | 1 |
| Solubility: LogS | -7.413 | nHRing | 1 |
| Solubility: LogP | 10.319 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 13 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 16.0528 |
| nHD | 0 | BPOL | 9.34724 |
| QED | 0.138 |
| Synth | 1.847 |
| Natural Product Likeliness | 0.145 |
| NR-PPAR-gamma | 0.056 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -5.039 |
| MDCK | 0.00000818 |
| BBB | 0.023 |
| PPB | 0.970819 |
| VDSS | 3.188 |
| FU | 0.0126032 |
| CYP1A2-inh | 0.096 |
| CYP1A2-sub | 0.155 |
| CYP2c19-inh | 0.222 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.067 |
| CYP2c9-sub | 0.947 |
| CYP2d6-inh | 0.239 |
| CYP2d6-sub | 0.022 |
| CYP3a4-inh | 0.246 |
| CYP3a4-sub | 0.031 |
| CL | 5.034 |
| T12 | 0.071 |
| hERG | 0.502 |
| Ames | 0.004 |
| ROA | 0.02 |
| SkinSen | 0.97 |
| Carcinogencity | 0.037 |
| EI | 0.938 |
| Respiratory | 0.802 |
| NR-Aromatase | 0.103 |
| Antiviral | No |
| Prediction | 0.957361 |